Consultants in Medical Oncology and Hematology Joins The US Oncology Network, Enhancing Its Ability to Deliver High-Quality Care throughout the Greater Philadelphia Area

Published: Wednesday, Jan 24, 2018

Philadelphia, Pa. (January 18, 2018) – Consultants in Medical Oncology and Hematology (CMOH), a premier provider of comprehensive medical oncology services throughout the Philadelphia region for nearly 30 years and a national leader in the development of patient and physician-focused value-based cancer care delivery models, has joined The US Oncology Network (The Network). The Network is the largest organization of its kind comprised of community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care.

By joining The Network, CMOH gains access to some of the most advanced oncology treatments available today, as well as innovative, proven solutions that can strengthen the practice’s ability to deliver high-quality, value-based care in convenient community locations. With the addition of CMOH, The Network extends its presence in the Northeast, while also enhancing its expertise in alternative, patient-focused, value-based payment models. The Network is supported by McKesson Specialty Health, an industry leader in solutions that empower the community patient care delivery system to advance the science, technology and quality of care.

“The Philadelphia market has a reputation for strong community-based oncology,” said Kirk Kaminsky, president, The US Oncology Network and Provider Services, McKesson Specialty Health. “We’re excited to bring The Network’s model to CMOH in addition to the other support services we provide Philadelphia-based oncologists.”

“Uniting with The US Oncology Network will further fuel our goal of the high-quality, patient-centered care that we have always provided, and enable us to offer even more advanced treatment options not usually available in a community setting,” said John D. Sprandio, M.D., medical oncologist and chief of Medical Oncology and Hematology at CMOH. “The vast resources of The Network will be invaluable in helping us continue to advance our agenda of providing progressively better care and quality of life for our patients while reducing unnecessary spending through improved care delivery. This is increasingly important to employers, local and national payers, as well as patients and their families who are facing increasing costs and rising out of pocket expenses in pursuit of the highest quality of cancer care."

By joining The Network, CMOH can collaborate with their colleagues across America through eTumor Boards and The Oncology Portal, drawing from the collective knowledge and expertise of more than 1,400 physicians in The Network. Additionally, by uniting with The Network, the practice gains the ability to offer patients novel clinical trials through US Oncology Research, a leader in bringing innovative therapies to patients in local communities across the nation. The organization has played a role in approximately 70 FDA-approved cancer therapies, about one-third of all cancer therapies approved by the FDA to date.

“Dr. Sprandio and his colleagues are changing the way cancer care is delivered with their innovative care delivery model, the Oncology Patient Centered Medical Home®, that improves patient care, provides a better patient experience and lowers costs through more effective care delivery,” said Chad Warnick, regional senior vice president at McKesson Specialty Health. “We are excited to have the opportunity to collaborate with and learn from them, as they share our common goal of advancing patient-focused cancer care while keeping community practices strong and vibrant in today’s value-based environment.”

With nine physicians and one advanced practice provider, CMOH offers patients and their families an enhanced level of services and cutting-edge protocols. The practice has four state-of-the-art treatment centers, with offices in Broomall, Glen Mills, Newtown Square and Exton. CMOH provides highly personalized, coordinated care based on a unique nationally recognized care delivery model designed by Dr. Sprandio, a recognized leader in the development of patient-centric, value-based care models. The practice developed propriety software (Iris™ Clinician Suite) and standardized processes to allow for its highly efficient, personalized approach to care, stressing patient engagement and communication to keep patients active and fully informed in every step of their treatment journey. The Iris™ Clinician Suite is central to the practice's success in relentlessly driving the consistency, quality and value of cancer care.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication